Private Placement

Spineway secures €1.5M in crucial financing amid rising losses, betting on its innovative ESP® disc and surgeon education to finally turn revenue into profit.

Data I/O reports a 59% sequential sales jump, but a surprise delay in its full earnings to analyze a complex $9M investment introduces critical uncertainty.

The firm's latest securitization isn't just another deal; it's a test of whether proprietary AI can master risk in a turbulent consumer credit market.

Processa Pharmaceuticals acquires Vidya Therapeutics and its key asset, VT-7208, backed by a $200M financing that radically overhauls the company's strategy.

A C$20M financing fuels Miata Metals' Suriname gold project, but it’s the strategic backing of heavyweight fund La Mancha that truly validates the bet.

A $50M insider investment fuels ProLogium's SPAC merger and its French gigafactory, signaling a strategic move to dominate Europe's advanced battery market.

With a new CMO and fresh funding, Spero Therapeutics is betting big on its immunology asset SP001. Can Dr. Zack guide it to success in a competitive field?

A breakthrough trial for a rare genetic disorder unlocks $50M in funding. We explore the novel RNA science, the savvy investment, and why it's all happening in Australia.

Radiopharm Theranostics secures crucial funding for its promising oncology pipeline, but a sharp stock drop reveals deep investor concerns about dilution.

Aldebaran Resources spins out Centauri Minerals, which just closed a $25M financing to fuel gold and copper exploration in Argentina's booming mining sector.

With its 33rd employee share program, Societe Generale isn't just boosting capital; it's investing in its people. How 54,000 employees became key to its future.

China SXT Pharma secured $9 million in a direct offering, but a catastrophic stock collapse reveals deep investor distrust in its survival strategy.

After clearing its debt and raising $15M, High-Trend International is flush with cash. But can it transform from a traditional shipper into a digital powerhouse?

Vibrantz Technologies' $200M deal with Finacity isn't just a loan; it's a masterclass in using receivables to fuel global growth amid financial pressure.

After its stock mysteriously surged over 2,000% intraday, China Pharma announced a $5M offering at a steep discount. A strategic move or a sign of strain?

Beyond the headlines of a $600M debt offering lies Howard Energy's shrewd maneuver to fortify its balance sheet and fuel future growth. What does it signal?

With a stunning $1.2B in new commitments, Great Rock Capital's growth highlights a seismic shift in finance, as private credit steps in to fund America's core.

Wereldhave defies market headwinds with strong rental growth and a fortified balance sheet, proving its 'LifeCentral' strategy is more than just a buzzword.

Edge intelligence firm RMX Industries adds former Texas Secretary of State John Scott to its board, a move that telegraphs a serious play for government contracts.

With a massive IPO and backing from Agnico Eagle, Cadillac Mines is not just raising capital; it's signaling a major shift in Canada's mining landscape.